CHELMSFORD, Mass. — ZOLL Medical Corporation (NASDAQ: ZOLL), a manufacturer of resuscitation devices and related software solutions, today reported that Mass.-based Armstrong Ambulance Service will standardize to ZOLL resuscitation equipment. In addition to deploying the ZOLL AutoPulse® Non-invasive Cardiac Support Pump on its ALS ambulances, Armstrong Ambulance purchased 17 E Series(tm) defibrillators as well as 13 AED Plus(tm) and 67 AED Pro® automated external defibrillators. Armstrong recently chose to standardize on ZOLL equipment as they prepare to open a state-of-the-art, 15,000-square-foot facility in Arlington, Mass. later in October.
In 1999, Armstrong was one of the first to deploy ZOLL’s RescueNet(tm) electronic data-management system, which allowed them to better manage many areas of their business. Armstrong realized improvements in the quality of patient documentation, as well as enhanced clarity on specific paramedic and EMT training needs. It also improved their billing and collections process.
According to Armstrong’s CEO Christina Larson, “From the beginning, founder Bill Armstrong always believed in deploying state-of-the-art technology. It is important to provide our staff with the latest tools they need to do their jobs. Giving them the proper equipment allows them to maintain a high level of patient care. ZOLL’s technology allows us to excel in the areas of clinical excellence, patient care, and business operations. This approach is what Armstrong requires to grow our business and be successful over time.”
About Armstrong Ambulance
Armstrong Ambulance Service was founded in 1946 with just one ambulance. Today, Armstrong is one of the largest privately owned and operated ambulance companies in Massachusetts, providing both Basic Life Support and Advanced Life Support services. It employs more than 450 people, and it has a fleet of more than 120 vehicles that operate out of 13 satellite offices throughout Eastern Massachusetts. Armstrong conducts more than 160,000 transports annually.
About ZOLL Medical Corporation
ZOLL Medical Corporation is committed to developing technologies that help advance the practice of resuscitation. With products for pacing, defibrillation, circulation, ventilation, and fluid resuscitation, ZOLL provides a comprehensive set of technologies that help clinicians, EMS professionals, and lay rescuers resuscitate sudden cardiac arrest or trauma victims. ZOLL also designs and markets software that automates the documentation and management of both clinical and non-clinical information.
ZOLL markets and sells its products in more than 140 countries. The Company has direct operations, distributor networks, and business partners throughout the U.S., Canada, Latin America, Europe, the Middle East, Asia, and Australia. For more information, visit www.zoll.com or call +1 (978) 421-9655.
Certain statements contained in this press release regarding matters that are not historical facts are “forward-looking” statements (as defined in the Private Securities Litigation Reform Act of 1995). Because such statements are subject to risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. Factors that could cause actual results to differ materially from those expressed or implied by such forward-looking statements include, but are not limited to, ZOLL’s ability to compete in the resuscitation business; acceptance of its recently launched products; changes in regulations affecting the healthcare industry; global economic conditions; and those other factors discussed in the section entitled “Risk Factors” in ZOLL’s Quarterly Report on Form 10-Q, which was filed with the SEC on August 11, 2006.